| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/19/2009 | CA2698645A1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent |
| 03/19/2009 | CA2698157A1 Novel polysaccharide immunogens from clostridium difficile |
| 03/19/2009 | CA2695517A1 Alkylsulfonyl-substituted thiazolide compounds |
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2036917A1 Novel aminoglycoside antibiotic |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036889A2 Substituted indoles and a method for the production and use thereof |
| 03/18/2009 | EP2036573A1 HLA binding peptides and their uses |
| 03/18/2009 | EP2036562A1 A1 adenosine receptor antagonist for preventing and treating tissue injury and sepsis associated with yersinia pestis infection |
| 03/18/2009 | EP2036556A1 Piperidone derivatives and medical uses thereof |
| 03/18/2009 | EP2036555A1 The use of derviate of pyridone for preventing and treating radioactive injury of lungs |
| 03/18/2009 | EP2036540A2 Improved injectable dispersions of propofol |
| 03/18/2009 | EP2035432A1 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 03/18/2009 | EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES |
| 03/18/2009 | EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 03/18/2009 | EP2035385A2 Inhibitors of akt (protein kinase b) |
| 03/18/2009 | EP2035025A1 Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
| 03/18/2009 | EP2035018A1 Pathogenic attenuation via the administration of an equilibiotic compound |
| 03/18/2009 | EP2035004A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 03/18/2009 | EP2034997A1 Antibacterial compositions |
| 03/18/2009 | EP2034996A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2000467A9 Hydrate for medical purposes |
| 03/18/2009 | EP1802311B1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c |
| 03/18/2009 | EP1768945B1 Substituted hydroxyacetophenon derivatives |
| 03/18/2009 | EP1615629B1 Peptide deformylase inhibitors |
| 03/18/2009 | EP1539927B1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2009 | EP1539151B1 Biaryl compounds having anti-infective activity |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1501846B1 Tricyclic macrolide antibacterial compounds |
| 03/18/2009 | EP1399499B1 Agent for the prevention and treatment of sexually transmitted diseases-i |
| 03/18/2009 | EP1389096B1 Delivery of opioids through an inhalation route |
| 03/18/2009 | EP1368044B1 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection |
| 03/18/2009 | EP1343815B1 Antibacterial treatments |
| 03/18/2009 | EP1283887B1 Chimeric arterivirus-like particles |
| 03/18/2009 | EP1077678A4 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 03/18/2009 | EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 03/18/2009 | CN101389760A Peptides effective in the treatment of tumors and other peptides requiring the removal or destruction of cells |
| 03/18/2009 | CN101389632A Spiroketals |
| 03/18/2009 | CN101389631A Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (PDT) |
| 03/18/2009 | CN101389607A Substituted arylsulfonamides as antiviral agents |
| 03/18/2009 | CN101389597A Carbonates of fenicol antibiotics |
| 03/18/2009 | CN101389344A Synthesized medicament and method for treating HIV |
| 03/18/2009 | CN101387646A Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 03/18/2009 | CN101386848A MiRNA with cell corpuscule as vector and preparation research approach thereof and application |
| 03/18/2009 | CN101386833A Recombinant bacterium of brucella abortus and use thereof |
| 03/18/2009 | CN101386832A Recombinant bacterium of brucella melitensis and use thereof |
| 03/18/2009 | CN101386831A Recombinant bacterium of brucella abortus with immunity labeling and use thereof |
| 03/18/2009 | CN101386830A Recombinant bacterium of brucella melitensis with immunity labeling and use thereof |
| 03/18/2009 | CN101386818A Extract of sea fungal culture and preparation method and application thereof |
| 03/18/2009 | CN101386649A High-stable anti-helicobacter pylori recombinant VacA specific egg yolk antibody and use thereof |
| 03/18/2009 | CN101386648A Neutralizing monoclonal antibodies against B type botulinum neurotoxin, preparation method and use thereof |
| 03/18/2009 | CN101386644A Pumpkin protein 2 and preparation method and application thereof |
| 03/18/2009 | CN101386641A Synthetic peptide vaccines for foot-and-mouth disease |
| 03/18/2009 | CN101386640A Variant cathelicidin-BF15 of cathelicidin-BF and use thereof |
| 03/18/2009 | CN101386620A Thiazole derivative and preparation method and application thereof |
| 03/18/2009 | CN101386606A 3-amino-7-dialkylamide substituted phenothiazines compounds and preparation method and use thereof |
| 03/18/2009 | CN101386593A Norfloxacin glutamate hydrate and preparation and use thereof |
| 03/18/2009 | CN101386591A Lamellarins alkaloid and and preparation method and use in anti-hiv thereof |
| 03/18/2009 | CN101385856A Controllable slow-releasing nano hydroxyapatite with efficient absorption for antalzyme and preparation method thereof |
| 03/18/2009 | CN101385854A Rabbit hemorrhagic disease vaccine and antigens |
| 03/18/2009 | CN101385853A Preparation of domestic adsorhed diphtheria tetanus and acellular pertussis combined vaccine without formaldehyde and merthiolate |
| 03/18/2009 | CN101385845A Traditional Chinese medicine preparation for treating hepatitis B |
| 03/18/2009 | CN101385842A Medicine for treating chronic hepatitis b and preparation method thereof |
| 03/18/2009 | CN101385840A Anluo Huaxian medicine and preparation method thereof |
| 03/18/2009 | CN101385831A Production method of antibiotic Chinese herbal medicine preparation |
| 03/18/2009 | CN101385825A Traditional Chinese medicine preparation for preventing and treating cold |
| 03/18/2009 | CN101385800A Skin-protection scream for foot |
| 03/18/2009 | CN101385783A Huganning tablets for treating chronic and urgent liver disease and preparation method thereof |
| 03/18/2009 | CN101385776A Anti influenza use of main chemical component and active component in scabriculous herbamoslae |
| 03/18/2009 | CN101385775A Medicine for treating tinea pedis and preparation method thereof |
| 03/18/2009 | CN101385772A Effervescence tablets for increasing natural immunity |
| 03/18/2009 | CN101385765A Compound sedum sarmentosum capsules and preparation method thereof |
| 03/18/2009 | CN101385763A Use of snow ganoderma lucidum total saponin in preparing antiviral property hepatitis medicine |
| 03/18/2009 | CN101385762A Composition of starwort total glycosidoprotein, preparation method and uses thereof |
| 03/18/2009 | CN101385750A Preparation method of effective ingredient of isatis root |
| 03/18/2009 | CN101385747A Extraction method of activity ingredient from katsura tree and uses thereof |
| 03/18/2009 | CN101385745A Agent which is anti-adhesive in relation to the pathogenic flora of the skin |
| 03/18/2009 | CN101385741A Use of polysaccharide sulfate as anti influenza virus medicine |
| 03/18/2009 | CN101385740A Use of polysaccharide sulfate as anti influenza virus medicine |
| 03/18/2009 | CN101385737A Antibiotic effective ingredient and use thereof |
| 03/18/2009 | CN101385732A Low dose entecavir formulation and use |
| 03/18/2009 | CN101385728A Eye drip preparation of balofloxacin or salt thereof and preparation method thereof |
| 03/18/2009 | CN101385720A Sitafloxacin hydrate capsules and preparation method thereof |
| 03/18/2009 | CN101385716A Sitafloxacin hydrate granules and preparation method thereof |
| 03/18/2009 | CN101385704A Compound sulfamonomethoxine sodium injection and preparation method thereof |
| 03/18/2009 | CN101385703A Cation adhesion type natamycin nano eye drops |
| 03/18/2009 | CN100469882C Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469788C 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469783C Oligose ,sulfating product and oligose cluster and its uses |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469769C Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469392C Antifungal medicine composition |
| 03/18/2009 | CN100469391C Use of human lysozyme in preparation of medicine for hemorrhoid |
| 03/18/2009 | CN100469375C Medicine for treating hepatitis and its preparing method |
| 03/18/2009 | CN100469369C Usage of stigmastane-3,5,6-triol and derivative for preparing antiviral remedy, and new stigmastane-3,5,6-triol derivatives |